MedPath

EMBODY ORTHOPAEDIC LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:2
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Not Applicable
Not yet recruiting
Conditions
Inflammatory Arthritis
Osteoarthritis, Hip
First Posted Date
2023-12-08
Last Posted Date
2023-12-08
Lead Sponsor
Embody Orthopaedic Limited
Target Recruit Count
200
Registration Number
NCT06162195

H1 Hip Resurfacing Arthroplasty

Active, not recruiting
Conditions
Hip Necrosis
Hip Dysplasia
Hip Osteoarthritis
First Posted Date
2017-10-31
Last Posted Date
2023-09-07
Lead Sponsor
Embody Orthopaedic Limited
Target Recruit Count
250
Registration Number
NCT03326804
Locations
🇬🇧

Charing Cross Hospital, London, United Kingdom

🇬🇧

Kind Edward VII's Hospital, London, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.